{"id":211421,"date":"2025-06-24T21:41:07","date_gmt":"2025-06-24T21:41:07","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/211421\/"},"modified":"2025-06-24T21:41:07","modified_gmt":"2025-06-24T21:41:07","slug":"in-just-4-months-ai-medical-scribe-abridge-doubles-valuation-to-5-3b","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/211421\/","title":{"rendered":"In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B"},"content":{"rendered":"<p id=\"speakable-summary\" class=\"wp-block-paragraph\">Abridge, an <a href=\"https:\/\/techcrunch.com\/2024\/06\/18\/how-abridge-became-one-of-the-most-talked-about-healthcare-ai-startups\/\" target=\"_blank\" rel=\"noopener\">AI startup automating medical notes<\/a>, has secured a $300 million Series E at a $5.3 billion valuation, according to the <a href=\"https:\/\/www.wsj.com\/articles\/abridge-whose-ai-app-takes-notes-for-doctors-valued-at-5-3-billion-at-funding-801825f3?gaa_at=eafs&amp;gaa_n=ASWzDAgfSz2WouXqpZ3rLtgHapE0BOKLg7vW-VID3ttnTgq9-bIOE57HsUB4xnu5kM0%3D&amp;gaa_ts=685aef02&amp;gaa_sig=Bwp8K7byKvpn1JkOrwYMrCwYWiJSz6m5niQj_Uw_8l0LNHUpkxGxf_RexVenHQzsHqbjLP9TWrGiUHyspi5Wfg%3D%3D\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Wall Street Journal<\/a>. The round, led by Andreessen Horowitz with participation from Khosla Ventures, follows the company\u2019s $250 million <a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/healthcare-startup-abridge-raises-250-million-enhance-ai-capabilities-2025-02-17\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">February fundraise<\/a> at a $2.75 billion valuation.<\/p>\n<p class=\"wp-block-paragraph\">The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry<strong> <\/strong>and integration with Epic Systems, the dominant health record software.<\/p>\n<p class=\"wp-block-paragraph\">In Q1, Abridge reached $117 million in contracted annual recurring revenue (a metric that includes all signed recurring contacts, including from customers that have still not been onboarded), <a href=\"https:\/\/www.theinformation.com\/articles\/abridge-talks-raise-5-billion-valuation-ai-health-startups-draw-investors?rc=em6blq\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">The Information reported<\/a> last month.<\/p>\n<p class=\"wp-block-paragraph\">Along with the fundraise, Abridge announced that it is expanding into converting medical notes from patient appointments into AI-powered medical codes, an offering that makes the company directly competitive with startups like CodaMetrix and a feature from its partner <a href=\"https:\/\/www.epic.com\/software\/ai-operations\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Epic Systems<\/a>.<\/p>\n<p class=\"wp-block-paragraph\">Abridge, which was founded by cardiologist Shiv Rao, claims that its AI scribe technology is <a href=\"https:\/\/www.abridge.com\/blog\/series-e\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">used by over 150<\/a> of the largest health systems in the U.S.<\/p>\n","protected":false},"excerpt":{"rendered":"Abridge, an AI startup automating medical notes, has secured a $300 million Series E at a $5.3 billion&hellip;\n","protected":false},"author":2,"featured_media":211422,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3094],"tags":[68321,84310,84311,51,3134,2902,16,15],"class_list":{"0":"post-211421","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-entrepreneurship","8":"tag-a16z","9":"tag-abridge","10":"tag-ai-note-taking","11":"tag-business","12":"tag-entrepreneurship","13":"tag-in-brief","14":"tag-uk","15":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114740519665521824","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/211421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=211421"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/211421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/211422"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=211421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=211421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=211421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}